-transparent.png){kind=logo}
Autologous marrow infusion has been attempted in three patients with chronic myeloid leukemia (two in blast crisis, one with severe myelofibrosis and pancytopenia) and one patient with acute lymphatic leukemia. One patient with blast crisis of CML expired prior to marrow infusion. One patient with myelofibrotic phase of CML is alive seven months post marrow infusion. The other two patients expired 6 and 16 days post marrow infusion. Bone-marrow repopulation is feasible in the face of severe myelofibrosis.
Related Publications
T Mahmood, and
W A Robinson, and
M Entringer
April 1991,
Bone marrow transplantation,
T Mahmood, and
W A Robinson, and
M Entringer
November 1993,
Transplantation,
T Mahmood, and
W A Robinson, and
M Entringer
May 2010,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
T Mahmood, and
W A Robinson, and
M Entringer
August 1999,
Haematologica,
T Mahmood, and
W A Robinson, and
M Entringer
June 1999,
Bone marrow transplantation,
T Mahmood, and
W A Robinson, and
M Entringer
January 1997,
Stem cells (Dayton, Ohio),
T Mahmood, and
W A Robinson, and
M Entringer
January 1996,
Stem cells (Dayton, Ohio),
T Mahmood, and
W A Robinson, and
M Entringer
December 2011,
Blood,
T Mahmood, and
W A Robinson, and
M Entringer
January 1995,
Haematologica,
T Mahmood, and
W A Robinson, and
M Entringer
August 1996,
Transfusion,
